Na Ra Han

Title: Na Ra Han: Innovator in Pharmaceutical Composition

Introduction

Na Ra Han is a notable inventor based in Yongin, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit autotaxin activity. His work is crucial for addressing various diseases that are linked to this enzyme.

Latest Patents

Na Ra Han holds a patent for a piperidine derivative and a pharmaceutical composition for inhibiting autotaxin. This patent includes a piperidine derivative compound, its hydrates, solvates, or pharmaceutically acceptable salts. The pharmaceutical composition is designed for the prevention or treatment of diseases related to autotaxin activity. The compound exhibits excellent inhibitory activity against autotaxin, making it effective for treating fibrotic diseases, inflammatory diseases, autoimmune diseases, respiratory diseases, cardiovascular diseases, metabolic diseases, cancer and cancer metastasis, ocular diseases, cholestatic forms, chronic pruritus, and organ transplant rejection.

Career Highlights

Na Ra Han is currently associated with Nextgen Bioscience Co., Ltd., where he continues to innovate in the pharmaceutical sector. His research and development efforts focus on creating effective treatments for complex diseases.

Collaborations

Na Ra Han collaborates with talented individuals in his field, including Bong Yong Lee and Young Ah Shin, who contribute to the advancement of their projects.

Conclusion

Na Ra Han's work in developing pharmaceutical compositions highlights his commitment to improving healthcare through innovative solutions. His contributions are paving the way for new treatments that can significantly impact patient outcomes.